espite ongoing and significant advancements in surgery that have allowed patients to recover faster and live fuller lives, people in low-income countries often do not have the same access to safe and affordable surgical care. This lack of access can transform otherwise treatable conditions and injuries into physically debilitating and economically devastating health threats.
Johnson & Johnson is working to address this inequity by transforming surgical care for the world’s most vulnerable people and communities. Bringing together the Global Public Health team at Johnson & Johnson and Johnson & Johnson MedTech, we are applying our world-class expertise, innovation, capabilities and convening power to address two key unmet needs in global surgery: trauma management and maternal care.
By advancing innovation to develop and deliver approaches, products and procedures designed specifically for use in resource-limited settings – at every step from the lab to the last mile of health delivery – we are committed to expanding access to quality surgical care in operation rooms around the world and enabling everyone, everywhere to live healthier lives.
Johnson & Johnson’s Global Surgery program builds on the expertise and legacy of the Johnson & Johnson MedTech, which has worked for over a century to revolutionize surgical systems and instruments for a range of medical conditions. The program will further drive impact by strengthening surgical programs and training, streamlining supply chains, reducing costs and equipping surgeons with the latest technologies, tailored to better meet the needs of undeserved communities. By collaborating with local organizations, the initiative is leveraging the best-in-class training capabilities of Johnson & Johnson to support local surgeons implementing new tools and standards of care. This lab-to-last-mile approach builds on the remarkable progress Johnson & Johnson has made to tackle some of the world’s greatest healthcare challenges, including HIV, tuberculosis, Ebola, and most recently, COVID-19.